These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 24919751)
41. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis. Ioannou K Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755 [TBL] [Abstract][Full Text] [Related]
42. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy. Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767 [TBL] [Abstract][Full Text] [Related]
43. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890 [TBL] [Abstract][Full Text] [Related]
44. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis. Yu Y; Bai F; Qin N; Liu W; Sun Q; Zhou Y; Yang J Nephron; 2018; 139(3):269-282. PubMed ID: 29539618 [TBL] [Abstract][Full Text] [Related]
45. [Relationship of renal lesions with urinary protein excretion in patients with overt diabetic nephropathy]. Okada T; Matsumoto H; Nakao T; Nagaoka Y; Yamada C; Shino T; Yoshino M; Hidaka H; Han MG; Ootani M; Shimizu T Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):475-85. PubMed ID: 10502941 [TBL] [Abstract][Full Text] [Related]
46. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044 [TBL] [Abstract][Full Text] [Related]
47. Insights into predicting diabetic nephropathy using urinary biomarkers. Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766 [TBL] [Abstract][Full Text] [Related]
48. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients. Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388 [TBL] [Abstract][Full Text] [Related]
49. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy. Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013 [TBL] [Abstract][Full Text] [Related]
50. Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats. Sharma V; Tikoo K Mol Cell Biochem; 2014 Mar; 388(1-2):95-111. PubMed ID: 24281856 [TBL] [Abstract][Full Text] [Related]
51. Acute and chronic glomerular damage is associated with reduced CD133 expression in urinary extracellular vesicles. Dimuccio V; Peruzzi L; Brizzi MF; Cocchi E; Fop F; Boido A; Gili M; Gallo S; Biancone L; Camussi G; Bussolati B Am J Physiol Renal Physiol; 2020 Feb; 318(2):F486-F495. PubMed ID: 31869243 [TBL] [Abstract][Full Text] [Related]
52. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients. El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886 [TBL] [Abstract][Full Text] [Related]
57. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980 [TBL] [Abstract][Full Text] [Related]
58. Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Diabetic Nephropathy in Type 1 Diabetic Patients. Sisman P; Gul OO; Dirican M; Bal AS; Cander S; Erturk E Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013365 [TBL] [Abstract][Full Text] [Related]
59. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Alter ML; Kretschmer A; Von Websky K; Tsuprykov O; Reichetzeder C; Simon A; Stasch JP; Hocher B Clin Lab; 2012; 58(7-8):659-71. PubMed ID: 22997966 [TBL] [Abstract][Full Text] [Related]
60. Urinary copper excretion in type 2 diabetic patients with nephropathy. Ito S; Fujita H; Narita T; Yaginuma T; Kawarada Y; Kawagoe M; Sugiyama T Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]